The U.S. Food and Drug Administration, an agency that regulates as much as 25 percent of every consumer dollar, is at the center of the drug and device delivery process. This panel examines what the agency is doing to ensure it has the necessary scientific expertise and technological framework. Panelists will address efforts that are seeking to modernize the review and approval process, take a close look at international collaboration on regulatory processes, and examine global regulatory challenges.